Cargando…

Digital expression profile of immune checkpoint genes in medulloblastomas identifies CD24 and CD276 as putative immunotherapy targets

INTRODUCTION: Medulloblastoma is the most common and lethal pediatric malignant brain tumor. It comprises four main molecular subgroups: WNT-activated, SHH-activated, Group 3, and Group 4. Medulloblastoma treatment is surgical resection, craniospinal radiation, and chemotherapy. However, many patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marques, Rui Ferreira, Moreno, Daniel Antunes, da Silva, Luciane, Leal, Leticia Ferro, de Paula, Flávia Escremim, Santana, Iara, Teixeira, Gustavo, Saggioro, Fabiano, Neder, Luciano, Junior, Carlos Almeida, Mançano, Bruna, Reis, Rui Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9941636/ https://www.ncbi.nlm.nih.gov/pubmed/36825029 http://dx.doi.org/10.3389/fimmu.2023.1062856

Ejemplares similares

High frequency of WNT-activated medulloblastomas with CTNNB1 wild type suggests a higher proportion of hereditary cases in a Latin-Iberian population
por: Moreno, Daniel Antunes, et al.
Publicado: (2023)

Expression patterns of the immune checkpoint ligand CD276 in urothelial carcinoma
por: Aicher, Wilhelm K., et al.
Publicado: (2021)

The Role of CD276 in Cancers
por: Liu, Shengzhuo, et al.
Publicado: (2021)

Genomic profile of two Brazilian choroid plexus tumors by whole-exome sequencing
por: Garcia, Felipe Antonio de Oliveira, et al.
Publicado: (2023)

New frontiers in immune checkpoint B7-H3 (CD276) research and drug development
por: Getu, Ayechew Adera, et al.
Publicado: (2023)

MiR‐1253 exerts tumor‐suppressive effects in medulloblastoma via inhibition of CDK6 and CD276 (B7‐H3)
por: Kanchan, Ranjana K., et al.
Publicado: (2020)

The immune checkpoint B7-H3 (CD276) regulates adipocyte progenitor metabolism and obesity development
por: Picarda, Elodie, et al.
Publicado: (2022)

CD276-CAR T cells and Dual-CAR T cells targeting CD276/FGFR4 promote rhabdomyosarcoma clearance in orthotopic mouse models
por: Timpanaro, Andrea, et al.
Publicado: (2023)

PBK phosphorylates MSL1 to elicit epigenetic modulation of CD276 in nasopharyngeal carcinoma
por: Wang, Meng-Yao, et al.
Publicado: (2021)

Correction: PBK phosphorylates MSL1 to elicit epigenetic modulation of CD276 in nasopharyngeal carcinoma
por: Wang, Meng-Yao, et al.
Publicado: (2021)

Correction: PBK phosphorylates MSL1 to elicit epigenetic modulation of CD276 in nasopharyngeal carcinoma
por: Wang, Meng-Yao, et al.
Publicado: (2023)

Prognostic Significance of CD276 in Non-small Cell Lung Cancer
por: Zhang, Changgong, et al.
Publicado: (2019)

B7-H3/CD276: An Emerging Cancer Immunotherapy
por: Zhou, Wu-Tong, et al.
Publicado: (2021)

CD276 as a Candidate Target for Immunotherapy in Medullary Thyroid Cancer
por: Hińcza-Nowak, Kinga, et al.
Publicado: (2023)

ERBB2 exon 20 insertions are rare in Brazilian non‐small cell lung cancer
por: de Oliveira Cavagna, Rodrigo, et al.
Publicado: (2022)

Astrocytes influence medulloblastoma phenotypes and CD133 surface expression
por: Gronseth, Emily, et al.
Publicado: (2020)

Silencing of CD276 suppresses lung cancer progression by regulating integrin signaling
por: Li, Fang, et al.
Publicado: (2020)

Elevated Expression of the Immune Checkpoint Ligand CD276 (B7-H3) in Urothelial Carcinoma Cell Lines Correlates Negatively with the Cell Proliferation
por: Harland, Niklas, et al.
Publicado: (2022)

CD276 Promotes Vasculogenic Mimicry Formation in Hepatocellular Carcinoma via the PI3K/AKT/MMPs Pathway
por: Cheng, Rui, et al.
Publicado: (2020)

Frequency of KRAS p.Gly12Cys Mutation in Brazilian Patients With Lung Cancer
por: Cavagna, Rodrigo, et al.
Publicado: (2021)

Cancer immune profiling unveils biomarkers, immunological pathways, and cell type score associated with glioblastoma patients’ survival
por: Moreno, Daniel Antunes, et al.
Publicado: (2022)

MEDB-47. CD4+ T cells restrict medulloblastoma growth and dissemination
por: Eisemann, Tanja, et al.
Publicado: (2022)

Identification of CD114 Membrane Receptors as a Molecular Target in Medulloblastomas
por: Monteiro, Jander Moreira, et al.
Publicado: (2023)

Tumor B7-H3 (CD276) Expression and Survival in Pancreatic Cancer
por: Inamura, Kentaro, et al.
Publicado: (2018)

CD276 is an important player in macrophage recruitment into the tumor and an upstream regulator for PAI-1
por: Durlanik, Sibel, et al.
Publicado: (2021)

COL10A1 promotes tumorigenesis by modulating CD276 in pancreatic adenocarcinoma
por: Xu, Qiaodong, et al.
Publicado: (2023)

Biomarkers for Immune Checkpoint Inhibitor Response in NSCLC: Current Developments and Applicability
por: Tostes, Katiane, et al.
Publicado: (2023)

Dissecting the role of putative CD81 binding regions of E2 in mediating HCV entry: Putative CD81 binding region 1 is not involved in CD81 binding
por: Rothwangl, Katharina B, et al.
Publicado: (2008)

Regulation of Immune Checkpoint Antigen CD276 (B7-H3) on Human Placenta-Derived Mesenchymal Stromal Cells in GMP-Compliant Cell Culture Media
por: Amend, Bastian, et al.
Publicado: (2023)

A risk assessment model of acute liver allograft rejection by genetic polymorphism of CD276
por: Yu, Xiaobo, et al.
Publicado: (2019)

Clinicopathological and Prognostic Characteristics of CD276 (B7-H3) Expression in Adrenocortical Carcinoma
por: Liang, Jiayu, et al.
Publicado: (2020)

Gene clusters based on OLIG2 and CD276 could distinguish molecular profiling in glioblastoma
por: Fu, Minjie, et al.
Publicado: (2021)

Comprehensive analysis of alternative polyadenylation regulators concerning CD276 and immune infiltration in bladder cancer
por: Xiong, Ming, et al.
Publicado: (2022)

A chemical screen for medulloblastoma identifies quercetin as a putative radiosensitizer
por: Lagerweij, Tonny, et al.
Publicado: (2016)

Simultaneous analysis of ALK, RET, and ROS1 gene fusions by NanoString in Brazilian lung adenocarcinoma patients
por: Novaes, Lázaro Antonio Campanha, et al.
Publicado: (2021)

Decreased m6A Modification of CD34/CD276(B7-H3) Leads to Immune Escape in Colon Cancer
por: Zhou, Yiran, et al.
Publicado: (2021)

Lateral interactions between CD276 and CD147 are essential for stemness in breast cancer: a novel insight from proximal proteome analysis
por: Seo, Yu Ri, et al.
Publicado: (2023)

Retinal outcomes of COVID-19: Possible role of CD147 and cytokine storm in infected patients with diabetes mellitus
por: Raony, Ícaro, et al.
Publicado: (2020)

Emerging Immune Checkpoint Molecules on Cancer Cells: CD24 and CD200
por: Moon, Sun Young, et al.
Publicado: (2023)

MicroRNA-187 inhibits tumor growth and invasion by directly targeting CD276 in colorectal cancer
por: Wang, Zheng-Shi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_aa4451fjvsd8hu934457uq6fsk